Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. 1-800-FLOWERS.COM, Inc.
23.1% sales growth and 17.9% return on equity
1-800-FLOWERS.COM, Inc., together with its subsidiaries, provides gifts for various occasions in the United States.
1-800-FLOWERS.COM, Inc.'s sales growth this year is anticipated to be 19.4% and 4.8% for next year.
Year-on-year quarterly revenue growth grew by 51.5%, now sitting on 1.59B for the twelve trailing months.
1-800-FLOWERS.COM, Inc.'s sales growth is a negative 0% for the present quarter and 23.1% for the next. The company's growth estimates for the ongoing quarter and the next is 23.2% and 46.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.9%.
1-800-FLOWERS.COM, Inc.'s Stock Yearly Top and Bottom Value
1-800-FLOWERS.COM, Inc.'s stock is valued at $26.04 at 10:22 EST, way under its 52-week high of $32.78 and way above its 52-week low of $11.15.
1-800-FLOWERS.COM, Inc.'s Moving Average
1-800-FLOWERS.COM, Inc.'s worth is way higher than its 50-day moving average of $22.74 and above its 200-day moving average of $24.85.2. Masco Corporation
6.6% sales growth and 451.65% return on equity
Masco Corporation designs, manufactures, and distributes home improvement and building products in North America, Europe, and internationally.
Masco Corporation's sales growth this year is expected to be 6.3% and 2.7% for next year.
Year-on-year quarterly revenue growth grew by 15.6%, now sitting on 6.97B for the twelve trailing months.
Masco Corporation's sales growth for the next quarter is 6.6%. The company's growth estimates for the present quarter and the next is 37% and 32.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 451.65%.
Masco Corporation's Stock Yearly Top and Bottom Value
Masco Corporation's stock is valued at $55.59 at 10:22 EST, under its 52-week high of $60.16 and way above its 52-week low of $27.04.
Masco Corporation's Moving Average
Masco Corporation's worth is above its 50-day moving average of $54.55 and above its 200-day moving average of $54.47.3. Unity Bancorp, Inc.
13% sales growth and 13.83% return on equity
Unity Bancorp, Inc. operates as the holding company for Unity Bank that provides commercial and retail banking products and services to individuals, small and medium sized businesses, and professional communities.
Unity Bancorp, Inc.'s sales growth this year is anticipated to be 12.2% and 5.4% for next year.
Year-on-year quarterly revenue growth grew by 7.9%, now sitting on 65.69M for the twelve trailing months.
Unity Bancorp, Inc.'s sales growth for the next quarter is 13%. The company's growth estimates for the present quarter and the next is 3.6% and 26.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.83%.
Unity Bancorp, Inc.'s Stock Yearly Top and Bottom Value
Unity Bancorp, Inc.'s stock is valued at $18.05 at 10:22 EST, way below its 52-week high of $24.15 and way above its 52-week low of $8.76.
Unity Bancorp, Inc.'s Moving Average
Unity Bancorp, Inc.'s value is higher than its 50-day moving average of $16.58 and way higher than its 200-day moving average of $14.20.4. PayPal
21.3% sales growth and 17.95% return on equity
PayPal Holdings, Inc. operates as a technology platform and digital payments company that enables digital and mobile payments on behalf of consumers and merchants worldwide.
PayPal's sales growth this year is expected to be 20.5% and 18.7% for next year.
Year-on-year quarterly revenue growth grew by 24.7%, now sitting on 20.3B for the twelve trailing months.
PayPal's sales growth for the next quarter is 21.3%. The company's growth estimates for the current quarter and the next is 15.1% and 48.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.95%.
PayPal's Stock Yearly Top and Bottom Value
PayPal's stock is valued at $243.46 at 10:22 EST, under its 52-week high of $244.25 and way higher than its 52-week low of $82.07.
PayPal's Moving Average
PayPal's worth is way above its 50-day moving average of $208.19 and way higher than its 200-day moving average of $192.06.Previous days news about PayPal
Gojek buys slice of Indonesian bank in biggest fintech deal yet. According to Bloomberg Quint on Fri Dec 18, "Gojek -- Indonesia's most valuable startup, backed by Facebook Inc. and PayPal Holdings Inc. -- aims to let users open bank accounts with Jago and then manage their finances through its app, according to an emailed statement. "
Big investors new to cryptocurrencies appear to be behind Bitcoin's rally to a record. According to CNBC on Fri Dec 18, "PayPal also added the ability for clients to buy bitcoin, which has opened up the market to millions of new buyers."
26 books c-suite leaders and billionaire investors say all entrepreneurs should read to become better leaders. According to Business Insider on Fri Dec 18, "Peter Thiel, billionaire investor and cofounder of PayPal, considers this book as Girard's masterpiece.", "Sculley, said that this 2014 bestseller by PayPal cofounder Peter Thiel is important for two reasons: It focuses on how you can harness technology to build a business of the future, and it enforces the importance of knowing what you're doing before you dive into a startup."
Successful founders match their funding to their revenue. here are 12 options to consider, from early days to venture.. According to Business Insider on Fri Dec 18,
How to invest in Bitcoin: the major ways to buy, their pros and cons, and the strategies to consider. According to Business Insider on Fri Dec 18, "PayPal isn't the only mainstream app cashing in on the crypto craze. ", "For example, take PayPal, which in November began enabling its US customers to buy, sell, and make purchases with bitcoin, as well as three other cryptocurrencies (ethereum, bitcoin cash, and litecoin)."
Peter thiel, angerMayer invest $35 million in U.S. biotech firm. According to Bloomberg Quint on Mon Dec 21,
Pandemic made this fintech fabulous. the phenomenon will continue.. According to Business Insider on Tue Dec 22, ""We see PayPal as the best positioned in the very near term, given its focus on e-commerce, but we believe it will ultimately give back a portion of recent growth," according to Morningstar. ", "While PayPal may face online payments competition, it enjoys superior brand enthusiasm and its move into the cryptocurrency universe is a long-term catalyst."
How China lost patience with jack ma, its loudest billionaire. According to Bloomberg Quint on Tue Dec 22, "With Silicon Valley-based PayPal Holdings Inc. as his model, Ma created the now ubiquitous Alipay service, used to pay for everything from loans to travel to McDonald's deliveries. "
PayPal check-cashing fees waived for second round of government-issued stimulus checks. According to Business Insider on Tue Dec 22, "SOURCE PayPal Holdings, Inc.", "For best performance, customers should have the latest version of the PayPal app installed and running the latest operating system on their mobile device."
5. Palomar Holdings, Inc.
33.2% sales growth and 6.66% return on equity
Palomar Holdings, Inc. provides specialty property insurance.
Palomar Holdings, Inc.'s sales growth this year is anticipated to be 43.6% and 37.7% for next year.
Year-on-year quarterly revenue growth grew by 47.7%, now sitting on 160.79M for the twelve trailing months.
Palomar Holdings, Inc.'s sales growth for the next quarter is 33.2%. The company's growth estimates for the present quarter and the next is a negative 54.2% and 8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.66%.
Palomar Holdings, Inc.'s Stock Yearly Top and Bottom Value
Palomar Holdings, Inc.'s stock is valued at $87.39 at 10:22 EST, way under its 52-week high of $121.87 and way above its 52-week low of $39.21.
Palomar Holdings, Inc.'s Moving Average
Palomar Holdings, Inc.'s value is way higher than its 50-day moving average of $78.33 and under its 200-day moving average of $89.67.6. Eli Lilly and Company
13.7% sales growth and 131.77% return on equity
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide.
Eli Lilly and Company's sales growth this year is anticipated to be 8.8% and 11.6% for next year.
Year-on-year quarterly revenue growth grew by 4.8%, now sitting on 23.21B for the twelve trailing months.
Eli Lilly and Company's sales growth for the next quarter is 13.7%. The company's growth estimates for the ongoing quarter and the next is 33.5% and 9.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 131.77%.
Eli Lilly and Company's Stock Yearly Top and Bottom Value
Eli Lilly and Company's stock is valued at $171.40 at 10:22 EST, under its 52-week high of $173.90 and way above its 52-week low of $117.06.
Eli Lilly and Company's Moving Average
Eli Lilly and Company's worth is way above its 50-day moving average of $148.65 and way higher than its 200-day moving average of $151.64.Previous days news about Eli Lilly and Company
Data from actt-2 trial of baricitinib in hospitalized Covid-19 patients supportive of the u. s. FDA EUA published in new england journal of medicine. According to Business Insider on Sat Dec 19, "TORONTO, Dec. 19, 2020 /CNW/ -On December 11, 2020, Eli Lilly and Company and Incyte announced that The New England Journal of Medicine published peer-reviewed results from the Adaptive COVID-19 Treatment Trial (ACTT-2) sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). ", "About Eli Lilly CanadaEli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. "
7. Blueprint Medicines Corporation
461.9% sales growth and 36.29% return on equity
Blueprint Medicines Corporation develops drugs of small molecule kinase inhibitors that target genomic drivers in genomically defined cancers, rare diseases, and cancer immunotherapy.
Blueprint Medicines Corporation's sales growth this year is anticipated to be 1077.3% and a negative 79.5% for next year.
Year-on-year quarterly revenue growth grew by 8053.2%, now sitting on 811.16M for the twelve trailing months.
Blueprint Medicines Corporation's sales growth for the next quarter is 461.9%. The company's growth estimates for the current quarter and the next is a negative 28.1% and 25.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 36.29%.
Blueprint Medicines Corporation's Stock Yearly Top and Bottom Value
Blueprint Medicines Corporation's stock is valued at $117.31 at 10:22 EST, under its 52-week high of $119.66 and way above its 52-week low of $43.29.
Blueprint Medicines Corporation's Moving Average
Blueprint Medicines Corporation's worth is way above its 50-day moving average of $103.25 and way higher than its 200-day moving average of $85.87.8. Qorvo, Inc.
19.1% sales growth and 10.28% return on equity
Qorvo, Inc. develops and commercializes technologies and products for wireless and wired connectivity worldwide.
Qorvo, Inc.'s sales growth this year is anticipated to be 18.5% and 9.5% for next year.
Year-on-year quarterly revenue growth grew by 31.4%, now sitting on 3.5B for the twelve trailing months.
Qorvo, Inc.'s sales growth is a negative 0% for the present quarter and 19.1% for the next. The company's growth estimates for the current quarter and the next is 43% and 26.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.28%.
Qorvo, Inc.'s Stock Yearly Top and Bottom Value
Qorvo, Inc.'s stock is valued at $152.64 at 10:22 EST, way below its 52-week high of $170.90 and way above its 52-week low of $67.54.